Connection between sleep cycle and cancer incidence
the ONA take:
A study by Virginia Tech biologists found that the benefits of a good night’s sleep include preventing cancer. These findings are likely to provide insight into the influence of the body’s internal clock on cancer development.
The researchers found that the protein human period 2 is responsible for regulating the body’s sleep cycle, or circadian rhythm. It also protects the body from developing sporadic forms of cancer. Unaltered, the human period 2 protein interacts with tumor suppressor proteins in cells to control cell division.
When environmental factors are altered, including sleep cycle disruption, the function of the protein is impaired. The connection between the protein, circadian rhythm, and cancer development was observed by studying various human and animal tumor cells.
The researchers found that repressing the human period 2 gene led to abnormal circadian rhythmicity and a malignant transformation. Researchers have long studied the connection between circadian rhythms and cancer development, particularly breast cancer, in women who work night shifts such as nurses and flight attendants.
Researchers are now working closely with patients to identify those who may be at risk for cancer due to the malfunction of the human period 2 protein and the gene that produces it.
Benefits of a good night’s sleep include preventing cancer.
Sign Up for Free e-newsletters
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Patients and Caregivers Worry About Cost of Cancer Care
- Open Hysterectomy Survival Rates Edge Minimally Invasive Procedures for Cervical Cancer
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Use of Corticosteroids With PD-1 or PD-L1 Inhibitors Associated With Poorer Outcomes in NSCLC
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Risk for Colon Cancer, Osteogenic Sarcoma Higher With Presence of Diamond-Blackfan Anemia
- G-CSF Support Increases Overall Survival, But Risk of Secondary Malignancies Also Higher
- Report From Childhood Cancer Survivor Study Identifies Long-Term Risks for VTE
- The Effect of Intravenous Hydration Strategy on Plasma Methotrexate Clearance During Intravenous High-dose Methotrexate Administration in Pediatric Oncology Patients
- Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|